Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2020 Aug 5;19(7):1443–1450.e6. doi: 10.1016/j.cgh.2020.07.065

Figure 1:

Figure 1:

Patient-level sensitivity corresponding to 10% screening-level false positive rate for T=6, 12, and 24 months prior to HCC diagnosis and at any time prior to HCC diagnosis (Ever) and the associated 95% bootstrap percentile intervals in patients diagnosed with early stage HCC and all HCC patients.